BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 837259)

  • 1. Hyperlipoproteinemia and cerebral strokes.
    Dekaban AS; Steusing JK; Stevens H
    Can J Neurol Sci; 1977 Feb; 4(1):13-7. PubMed ID: 837259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipoproteinemia in occlusive cerebrovascular disease.
    Mathew NT; Davis D; Meyer JS; Chandar K
    JAMA; 1975 Apr; 232(3):262-6. PubMed ID: 1173117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typing of hyperlipoproteinemia in an Israel hospital.
    Eisenberg S
    Isr J Med Sci; 1976 Nov; 12(11):1261-8. PubMed ID: 1017927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;
    Einarsson K; Hellström K; Kallner M
    J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary artery reserve in patients with hyperlipoproteinemias (author's transl)].
    Kaffarnik H; Braun B; Eltze C; Hausmann L; Mühlfellner G; Mühlfellner O; Neitzert A; Schneider J; Schubotz R; Zehner J
    Z Kardiol; 1978 Jul; 67(7):481-6. PubMed ID: 685378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The serum triglycerides and their role as a coronary risk factor (author's transl)].
    Pristautz H; Pavek P; Klein W
    Z Kardiol; 1977 May; 66(5):216-9. PubMed ID: 878547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, biological and genetic study of 500 cases of mixed hyperlipemia].
    De Gennes JL; Turpin G; Truffert J
    Ann Med Interne (Paris); 1977 Apr; 128(4):315-24. PubMed ID: 883728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
    Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum lipid profile in surgically treated patients with coronary arteriosclerosis.
    Allard C; Ruscito O; Goulet C
    Surg Gynecol Obstet; 1971 Nov; 133(5):807-11. PubMed ID: 5111117
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipids in ischemic stroke subtypes.
    Laloux P; Galanti L; Jamart J
    Acta Neurol Belg; 2004 Mar; 104(1):13-9. PubMed ID: 15143957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood lipid patterns in ischemic heart disease and cerebrovascular diseases].
    Gaglio M; Caruso G; Milone A; Trovato GM; Vancheri FS
    Cardiologia; 1984; 29(3-4):203-10. PubMed ID: 6541939
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
    Schwartzkopff W; Russ E
    MMW Munch Med Wochenschr; 1975 May; 117(19):827-30. PubMed ID: 805950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Features of lipid metabolism in patients of different sexes and ages with dyscirculatory encephalopathy].
    Shprakh VV; Burtsev EM; Ruzhnikova TV; Naumova TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1308-13. PubMed ID: 4072526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.